Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological and Immunomodulatory Effect of Hemoadsorption With Macroporous Resin Cartridges in Septic Shock and Refractory Septic Shock Two Parallel Open-label Randomized Pilot Trials.

NCT07715110 is registered in ClinicalTrials.gov with Miguel Sanchez Garcia as lead sponsor.

NCT NCT07715110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07715110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological and Immunomodulatory Effect of Hemoadsorption With Macroporous Resin Cartridges in Septic Shock and Refractory Septic Shock Two Parallel Open-label Randomized Pilot Trials.
Lead sponsor
Miguel Sanchez Garcia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 7, 2027
Completion date
June 30, 2029
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemoadsorption, hemoperfusion, multiple organ dysfunction, sepsis, septic shock, vasopressor resistance